Breckenridge debuts generic Ambien CR
Ambien CR and its generics had a market value of $42 million during the 12 months ended May 2021, according to industry sales data.
Breckenridge is offering zolpidem tartrate extended-release tablets.
The product, which is the generic of Ambien CR, is manufactured by Centaur Pharmaceuticals. Breckenridge will market the product in its own label and offer 6.25 mg and 12.5 mg strengths in bottles of 100.
Ambien CR and its generics had a market value of $42 million during the 12 months ended May 2021, according to industry sales data.